From 1abd94cdcedf6eab1b64a48ea3ba3a69f4ada35c Mon Sep 17 00:00:00 2001
From: =?UTF-8?q?=E9=BD=90=E6=96=8C?= <1134087124@qq.com>
Date: Sat, 31 May 2025 00:00:04 +0800
Subject: [PATCH 01/34] =?UTF-8?q?=E4=BF=AE=E6=94=B9=E7=AE=80=E4=BB=8B?=
=?UTF-8?q?=EF=BC=8CPC=E5=9B=BE=E8=A1=A8?=
MIME-Version: 1.0
Content-Type: text/plain; charset=UTF-8
Content-Transfer-Encoding: 8bit
---
.../customEcharts/size1920/index.vue | 31 +++++++++++--------
src/views/boarddirectors/size1440/index.vue | 6 ++--
src/views/boarddirectors/size1920/index.vue | 6 ++--
src/views/boarddirectors/size375/index.vue | 6 ++--
src/views/boarddirectors/size768/index.vue | 6 ++--
5 files changed, 30 insertions(+), 25 deletions(-)
diff --git a/src/components/customEcharts/size1920/index.vue b/src/components/customEcharts/size1920/index.vue
index 1708411..d1ff55e 100644
--- a/src/components/customEcharts/size1920/index.vue
+++ b/src/components/customEcharts/size1920/index.vue
@@ -78,12 +78,15 @@ const initEcharts = (data) => {
const yAxisData = data.map((item) => item.price)
console.error(xAxisData, yAxisData)
// 基于准备好的dom，初始化echarts实例
- myCharts = echarts.init(document.getElementById('myEcharts'))
+ myCharts = echarts.init(document.getElementById('myEcharts'), null, {
+ renderer: 'canvas',
+ useDirtyRect: true
+ })
// 绘制图表
myCharts.setOption({
- // title: {
- // text: 'FiEE, Inc. Stock Price History',
- // },
+ animation: false,
+ progressive: 500,
+ progressiveThreshold: 3000,
tooltip: {
trigger: 'axis',
axisPointer: {
@@ -97,6 +100,11 @@ const initEcharts = (data) => {
const p = params[0]
return `${p.axisValue}
Price: ${p.data}`
},
+ triggerOn: 'mousemove',
+ enterable: true,
+ confine: true,
+ hideDelay: 100,
+ showDelay: 0
},
xAxis: {
data: xAxisData,
@@ -111,15 +119,8 @@ const initEcharts = (data) => {
axisLabel: {
color: '#323232',
fontWeight: 'bold',
- // formatter: function (value) {
- // return value ? value.split('-')[0] : ''
- // },
- // interval: function (index, value) {
- // if (index === 0) return true;
- // const axisData = this && this.axis && this.axis.data ? this.axis.data : [];
- // if (!axisData[index - 1]) return true;
- // return value.split('-')[0] !== axisData[index - 1].split('-')[0];
- // },
+ interval: 'auto',
+ hideOverlap: true
},
},
yAxis: {
@@ -169,6 +170,10 @@ const initEcharts = (data) => {
symbolSize: 24,
data: [],
},
+ progressive: 500,
+ progressiveThreshold: 3000,
+ large: true,
+ largeThreshold: 2000
},
],
diff --git a/src/views/boarddirectors/size1440/index.vue b/src/views/boarddirectors/size1440/index.vue
index aee8f7b..2b85bba 100644
--- a/src/views/boarddirectors/size1440/index.vue
+++ b/src/views/boarddirectors/size1440/index.vue
@@ -39,17 +39,17 @@ const otherDirectors = [
"Previously served as the treasury director of Taifeng Cultural Communication Co., Ltd where she oversees its financial matters from November 2018 to November 2024. Prior to that, Ms. Cao served as a business manager of Yangfeng Art Exchange Co., Ltd from February 2016 to October 2018. From March 2011 to January 2016, she served as the treasury officer of financial department of Suzhou Industrial Park Xinfushida Plastic Profile Products Co., Ltd.",
},
{
- name: "David Lazar",
+ name: "David E. Lazar",
title: "Director",
contain:
- "Currently serves as President and Chief Executive Officer of Natan & Associates, LLC, a consulting firm offering chief financial officer services to public and private companies in a variety of industries, since 2007. Mr. Natan previously served as a Director of the Company from November 2023 to February 2025. From February 2010 to May 2020, Mr. Natan served as Chief Executive Officer of ForceField Energy, Inc. (OTCMKTS: FNRG), a company focused on the solar industry and LED lighting products. From February 2002 to November 2007, Mr. Natan served as Executive Vice President of Reporting and Chief Financial Officer of PharmaNet Development Group, Inc., a drug development services company, and, from June 1995 to February 2002, as Chief Financial Officer and Vice President of Global Technovations, Inc., a manufacturer and marketer of oil analysis instruments and speakers and speaker components. Prior to that, Mr. Natan served in various roles of increasing responsibility with Deloitte & Touche LLP, a global consulting firm. Mr. Natan currently serves as a member of the Board of Directors and Chair of the Audit Committee of Sunshine Biopharma, Inc. (Nasdaq: SBFM), a pharmaceutical and nutritional supplement company, since February 2022. Previously, Mr. Natan has served as a director for the following public companies: Global Technovations, Forcefield Energy, Titan Pharmaceuticals (Nasdaq: TTNP), Vivakor Inc. (Nasdaq: VIVK), NetBrands Corp. (OTC: NBND), and OpGen Inc. (OTC: OPGN), and Cyclacel Pharmaceuticals (Nasdaq: CYCC). Mr. Natan holds a B.A. in Economics from Boston University.",
+ "Served as the Chief Executive Officer of OpGen, Inc., a precision medicine company listed on the Nasdaq (OPGN) since April 11, 2024, where he also servs as a director and board chairman, beginning on March 25, 2024. Mr. Lazar served as the Chief Executive Officer of Titan Pharmaceuticals Inc. listed on the Nasdaq (TTNP) from August 2022 through April 11, 2024, where he also served as a director and board chairman from August 2022 until October 2023. He has also served as the CEO of Custodian Ventures LLC, a company which specializes in assisting distressed public companies through custodianship, since February 2018, and Activist Investing LLC, an actively managed private investment fund, since March 2018. Previously, Mr. Lazar served as Managing Partner at Zenith Partners International Inc., a boutique consulting firm, from July 2012 to April 2018. In his role as Chief Executive Officer of Custodian Ventures LLC, Mr. Lazar has successfully served as a custodian to numerous public companies across a wide range of industries.",
},
{
name: "David Natan",
title: "Director",
contain:
- "David Natan,age 72, currently serves as President and Chief Executive Officer of Natan & Associates, LLC, a consulting firm offering chief financialofficer services to public and private companies in a variety of industries, since 2007. Mr. Natan previously served as a Director of the Company fromNovember 2023 to February 2025. From February 2010 to May 2020, Mr. Natan served as Chief Executive Officer of ForceField Energy, Inc.(OTCMKTS: FNRG), a company focused on the solar industry and LED lighting products. From February 2002 to November 2007, Mr. Natan served asExecutive Vice President of Reporting and Chief Financial Officer of PharmaNet Development Group, Inc., a drug development services company, and,from June 1995 to February 2002, as Chief Financial Officer and Vice President of Global Technovations, Inc., a manufacturer and marketer of oil analysisinstruments and speakers and speaker components. Prior to that, Mr. Natan served in various roles of increasing responsibility with Deloitte & Touche LLP,a global consulting firm. Mr. Natan currently serves as a member of the Board of Directors and Chair of the Audit Committee of Sunshine Biopharma, Inc.(Nasdaq: SBFM), a pharmaceutical and nutritional supplement company, since February 2022. Previously, Mr. Natan has served as a director for thefollowing public companies: Global Technovations, Forcefield Energy, Titan Pharmaceuticals (Nasdaq: TTNP), Vivakor Inc. (Nasdaq: VIVK), NetBrandsCorp. (OTC: NBND), and OpGen Inc. (OTC: OPGN), and Cyclacel Pharmaceuticals (Nasdaq: CYCC). Mr. Natan holds a B.A. in Economics from Boston University.",
+ "Currently serves as President and Chief Executive Officer of Natan & Associates, LLC, a consulting firm offering chief financial officer services to public and private companies in a variety of industries, since 2007. Mr. Natan previously served as a Director of the Company from November 2023 to February 2025. From February 2010 to May 2020, Mr. Natan served as Chief Executive Officer of ForceField Energy, Inc. (OTCMKTS: FNRG), a company focused on the solar industry and LED lighting products. From February 2002 to November 2007, Mr. Natan served as Executive Vice President of Reporting and Chief Financial Officer of PharmaNet Development Group, Inc., a drug development services company, and, from June 1995 to February 2002, as Chief Financial Officer and Vice President of Global Technovations, Inc., a manufacturer and marketer of oil analysis instruments and speakers and speaker components. Prior to that, Mr. Natan served in various roles of increasing responsibility with Deloitte & Touche LLP, a global consulting firm. Mr. Natan currently serves as a member of the Board of Directors and Chair of the Audit Committee of Sunshine Biopharma, Inc. (Nasdaq: SBFM), a pharmaceutical and nutritional supplement company, since February 2022. Previously, Mr. Natan has served as a director for the following public companies: Global Technovations, Forcefield Energy, Titan Pharmaceuticals (Nasdaq: TTNP), Vivakor Inc. (Nasdaq: VIVK), NetBrands Corp. (OTC: NBND), and OpGen Inc. (OTC: OPGN), and Cyclacel Pharmaceuticals (Nasdaq: CYCC). Mr. Natan holds a B.A. in Economics from Boston University.",
},
{
name: "Chan Oi Fat",
diff --git a/src/views/boarddirectors/size1920/index.vue b/src/views/boarddirectors/size1920/index.vue
index affeabf..0ec6fbd 100644
--- a/src/views/boarddirectors/size1920/index.vue
+++ b/src/views/boarddirectors/size1920/index.vue
@@ -35,17 +35,17 @@ const otherDirectors = [
"Previously served as the treasury director of Taifeng Cultural Communication Co., Ltd where she oversees its financial matters from November 2018 to November 2024. Prior to that, Ms. Cao served as a business manager of Yangfeng Art Exchange Co., Ltd from February 2016 to October 2018. From March 2011 to January 2016, she served as the treasury officer of financial department of Suzhou Industrial Park Xinfushida Plastic Profile Products Co., Ltd.",
},
{
- name: "David Lazar",
+ name: "David E. Lazar",
title: "Director",
contain:
- "Currently serves as President and Chief Executive Officer of Natan & Associates, LLC, a consulting firm offering chief financial officer services to public and private companies in a variety of industries, since 2007. Mr. Natan previously served as a Director of the Company from November 2023 to February 2025. From February 2010 to May 2020, Mr. Natan served as Chief Executive Officer of ForceField Energy, Inc. (OTCMKTS: FNRG), a company focused on the solar industry and LED lighting products. From February 2002 to November 2007, Mr. Natan served as Executive Vice President of Reporting and Chief Financial Officer of PharmaNet Development Group, Inc., a drug development services company, and, from June 1995 to February 2002, as Chief Financial Officer and Vice President of Global Technovations, Inc., a manufacturer and marketer of oil analysis instruments and speakers and speaker components. Prior to that, Mr. Natan served in various roles of increasing responsibility with Deloitte & Touche LLP, a global consulting firm. Mr. Natan currently serves as a member of the Board of Directors and Chair of the Audit Committee of Sunshine Biopharma, Inc. (Nasdaq: SBFM), a pharmaceutical and nutritional supplement company, since February 2022. Previously, Mr. Natan has served as a director for the following public companies: Global Technovations, Forcefield Energy, Titan Pharmaceuticals (Nasdaq: TTNP), Vivakor Inc. (Nasdaq: VIVK), NetBrands Corp. (OTC: NBND), and OpGen Inc. (OTC: OPGN), and Cyclacel Pharmaceuticals (Nasdaq: CYCC). Mr. Natan holds a B.A. in Economics from Boston University.",
+ "Served as the Chief Executive Officer of OpGen, Inc., a precision medicine company listed on the Nasdaq (OPGN) since April 11, 2024, where he also servs as a director and board chairman, beginning on March 25, 2024. Mr. Lazar served as the Chief Executive Officer of Titan Pharmaceuticals Inc. listed on the Nasdaq (TTNP) from August 2022 through April 11, 2024, where he also served as a director and board chairman from August 2022 until October 2023. He has also served as the CEO of Custodian Ventures LLC, a company which specializes in assisting distressed public companies through custodianship, since February 2018, and Activist Investing LLC, an actively managed private investment fund, since March 2018. Previously, Mr. Lazar served as Managing Partner at Zenith Partners International Inc., a boutique consulting firm, from July 2012 to April 2018. In his role as Chief Executive Officer of Custodian Ventures LLC, Mr. Lazar has successfully served as a custodian to numerous public companies across a wide range of industries.",
},
{
name: "David Natan",
title: "Director",
contain:
- "David Natan,age 72, currently serves as President and Chief Executive Officer of Natan & Associates, LLC, a consulting firm offering chief financialofficer services to public and private companies in a variety of industries, since 2007. Mr. Natan previously served as a Director of the Company fromNovember 2023 to February 2025. From February 2010 to May 2020, Mr. Natan served as Chief Executive Officer of ForceField Energy, Inc.(OTCMKTS: FNRG), a company focused on the solar industry and LED lighting products. From February 2002 to November 2007, Mr. Natan served asExecutive Vice President of Reporting and Chief Financial Officer of PharmaNet Development Group, Inc., a drug development services company, and,from June 1995 to February 2002, as Chief Financial Officer and Vice President of Global Technovations, Inc., a manufacturer and marketer of oil analysisinstruments and speakers and speaker components. Prior to that, Mr. Natan served in various roles of increasing responsibility with Deloitte & Touche LLP,a global consulting firm. Mr. Natan currently serves as a member of the Board of Directors and Chair of the Audit Committee of Sunshine Biopharma, Inc.(Nasdaq: SBFM), a pharmaceutical and nutritional supplement company, since February 2022. Previously, Mr. Natan has served as a director for thefollowing public companies: Global Technovations, Forcefield Energy, Titan Pharmaceuticals (Nasdaq: TTNP), Vivakor Inc. (Nasdaq: VIVK), NetBrandsCorp. (OTC: NBND), and OpGen Inc. (OTC: OPGN), and Cyclacel Pharmaceuticals (Nasdaq: CYCC). Mr. Natan holds a B.A. in Economics from Boston University.",
+ "Currently serves as President and Chief Executive Officer of Natan & Associates, LLC, a consulting firm offering chief financial officer services to public and private companies in a variety of industries, since 2007. Mr. Natan previously served as a Director of the Company from November 2023 to February 2025. From February 2010 to May 2020, Mr. Natan served as Chief Executive Officer of ForceField Energy, Inc. (OTCMKTS: FNRG), a company focused on the solar industry and LED lighting products. From February 2002 to November 2007, Mr. Natan served as Executive Vice President of Reporting and Chief Financial Officer of PharmaNet Development Group, Inc., a drug development services company, and, from June 1995 to February 2002, as Chief Financial Officer and Vice President of Global Technovations, Inc., a manufacturer and marketer of oil analysis instruments and speakers and speaker components. Prior to that, Mr. Natan served in various roles of increasing responsibility with Deloitte & Touche LLP, a global consulting firm. Mr. Natan currently serves as a member of the Board of Directors and Chair of the Audit Committee of Sunshine Biopharma, Inc. (Nasdaq: SBFM), a pharmaceutical and nutritional supplement company, since February 2022. Previously, Mr. Natan has served as a director for the following public companies: Global Technovations, Forcefield Energy, Titan Pharmaceuticals (Nasdaq: TTNP), Vivakor Inc. (Nasdaq: VIVK), NetBrands Corp. (OTC: NBND), and OpGen Inc. (OTC: OPGN), and Cyclacel Pharmaceuticals (Nasdaq: CYCC). Mr. Natan holds a B.A. in Economics from Boston University.",
},
{
name: "Chan Oi Fat",
diff --git a/src/views/boarddirectors/size375/index.vue b/src/views/boarddirectors/size375/index.vue
index 52357f8..b83c131 100644
--- a/src/views/boarddirectors/size375/index.vue
+++ b/src/views/boarddirectors/size375/index.vue
@@ -35,17 +35,17 @@ const otherDirectors = [
"Previously served as the treasury director of Taifeng Cultural Communication Co., Ltd where she oversees its financial matters from November 2018 to November 2024. Prior to that, Ms. Cao served as a business manager of Yangfeng Art Exchange Co., Ltd from February 2016 to October 2018. From March 2011 to January 2016, she served as the treasury officer of financial department of Suzhou Industrial Park Xinfushida Plastic Profile Products Co., Ltd.",
},
{
- name: "David Lazar",
+ name: "David E. Lazar",
title: "Director",
contain:
- "Currently serves as President and Chief Executive Officer of Natan & Associates, LLC, a consulting firm offering chief financial officer services to public and private companies in a variety of industries, since 2007. Mr. Natan previously served as a Director of the Company from November 2023 to February 2025. From February 2010 to May 2020, Mr. Natan served as Chief Executive Officer of ForceField Energy, Inc. (OTCMKTS: FNRG), a company focused on the solar industry and LED lighting products. From February 2002 to November 2007, Mr. Natan served as Executive Vice President of Reporting and Chief Financial Officer of PharmaNet Development Group, Inc., a drug development services company, and, from June 1995 to February 2002, as Chief Financial Officer and Vice President of Global Technovations, Inc., a manufacturer and marketer of oil analysis instruments and speakers and speaker components. Prior to that, Mr. Natan served in various roles of increasing responsibility with Deloitte & Touche LLP, a global consulting firm. Mr. Natan currently serves as a member of the Board of Directors and Chair of the Audit Committee of Sunshine Biopharma, Inc. (Nasdaq: SBFM), a pharmaceutical and nutritional supplement company, since February 2022. Previously, Mr. Natan has served as a director for the following public companies: Global Technovations, Forcefield Energy, Titan Pharmaceuticals (Nasdaq: TTNP), Vivakor Inc. (Nasdaq: VIVK), NetBrands Corp. (OTC: NBND), and OpGen Inc. (OTC: OPGN), and Cyclacel Pharmaceuticals (Nasdaq: CYCC). Mr. Natan holds a B.A. in Economics from Boston University.",
+ "Served as the Chief Executive Officer of OpGen, Inc., a precision medicine company listed on the Nasdaq (OPGN) since April 11, 2024, where he also servs as a director and board chairman, beginning on March 25, 2024. Mr. Lazar served as the Chief Executive Officer of Titan Pharmaceuticals Inc. listed on the Nasdaq (TTNP) from August 2022 through April 11, 2024, where he also served as a director and board chairman from August 2022 until October 2023. He has also served as the CEO of Custodian Ventures LLC, a company which specializes in assisting distressed public companies through custodianship, since February 2018, and Activist Investing LLC, an actively managed private investment fund, since March 2018. Previously, Mr. Lazar served as Managing Partner at Zenith Partners International Inc., a boutique consulting firm, from July 2012 to April 2018. In his role as Chief Executive Officer of Custodian Ventures LLC, Mr. Lazar has successfully served as a custodian to numerous public companies across a wide range of industries.",
},
{
name: "David Natan",
title: "Director",
contain:
- "David Natan,age 72, currently serves as President and Chief Executive Officer of Natan & Associates, LLC, a consulting firm offering chief financialofficer services to public and private companies in a variety of industries, since 2007. Mr. Natan previously served as a Director of the Company fromNovember 2023 to February 2025. From February 2010 to May 2020, Mr. Natan served as Chief Executive Officer of ForceField Energy, Inc.(OTCMKTS: FNRG), a company focused on the solar industry and LED lighting products. From February 2002 to November 2007, Mr. Natan served asExecutive Vice President of Reporting and Chief Financial Officer of PharmaNet Development Group, Inc., a drug development services company, and,from June 1995 to February 2002, as Chief Financial Officer and Vice President of Global Technovations, Inc., a manufacturer and marketer of oil analysisinstruments and speakers and speaker components. Prior to that, Mr. Natan served in various roles of increasing responsibility with Deloitte & Touche LLP,a global consulting firm. Mr. Natan currently serves as a member of the Board of Directors and Chair of the Audit Committee of Sunshine Biopharma, Inc.(Nasdaq: SBFM), a pharmaceutical and nutritional supplement company, since February 2022. Previously, Mr. Natan has served as a director for thefollowing public companies: Global Technovations, Forcefield Energy, Titan Pharmaceuticals (Nasdaq: TTNP), Vivakor Inc. (Nasdaq: VIVK), NetBrandsCorp. (OTC: NBND), and OpGen Inc. (OTC: OPGN), and Cyclacel Pharmaceuticals (Nasdaq: CYCC). Mr. Natan holds a B.A. in Economics from Boston University.",
+ "Currently serves as President and Chief Executive Officer of Natan & Associates, LLC, a consulting firm offering chief financial officer services to public and private companies in a variety of industries, since 2007. Mr. Natan previously served as a Director of the Company from November 2023 to February 2025. From February 2010 to May 2020, Mr. Natan served as Chief Executive Officer of ForceField Energy, Inc. (OTCMKTS: FNRG), a company focused on the solar industry and LED lighting products. From February 2002 to November 2007, Mr. Natan served as Executive Vice President of Reporting and Chief Financial Officer of PharmaNet Development Group, Inc., a drug development services company, and, from June 1995 to February 2002, as Chief Financial Officer and Vice President of Global Technovations, Inc., a manufacturer and marketer of oil analysis instruments and speakers and speaker components. Prior to that, Mr. Natan served in various roles of increasing responsibility with Deloitte & Touche LLP, a global consulting firm. Mr. Natan currently serves as a member of the Board of Directors and Chair of the Audit Committee of Sunshine Biopharma, Inc. (Nasdaq: SBFM), a pharmaceutical and nutritional supplement company, since February 2022. Previously, Mr. Natan has served as a director for the following public companies: Global Technovations, Forcefield Energy, Titan Pharmaceuticals (Nasdaq: TTNP), Vivakor Inc. (Nasdaq: VIVK), NetBrands Corp. (OTC: NBND), and OpGen Inc. (OTC: OPGN), and Cyclacel Pharmaceuticals (Nasdaq: CYCC). Mr. Natan holds a B.A. in Economics from Boston University.",
},
{
name: "Chan Oi Fat",
diff --git a/src/views/boarddirectors/size768/index.vue b/src/views/boarddirectors/size768/index.vue
index aee8f7b..2b85bba 100644
--- a/src/views/boarddirectors/size768/index.vue
+++ b/src/views/boarddirectors/size768/index.vue
@@ -39,17 +39,17 @@ const otherDirectors = [
"Previously served as the treasury director of Taifeng Cultural Communication Co., Ltd where she oversees its financial matters from November 2018 to November 2024. Prior to that, Ms. Cao served as a business manager of Yangfeng Art Exchange Co., Ltd from February 2016 to October 2018. From March 2011 to January 2016, she served as the treasury officer of financial department of Suzhou Industrial Park Xinfushida Plastic Profile Products Co., Ltd.",
},
{
- name: "David Lazar",
+ name: "David E. Lazar",
title: "Director",
contain:
- "Currently serves as President and Chief Executive Officer of Natan & Associates, LLC, a consulting firm offering chief financial officer services to public and private companies in a variety of industries, since 2007. Mr. Natan previously served as a Director of the Company from November 2023 to February 2025. From February 2010 to May 2020, Mr. Natan served as Chief Executive Officer of ForceField Energy, Inc. (OTCMKTS: FNRG), a company focused on the solar industry and LED lighting products. From February 2002 to November 2007, Mr. Natan served as Executive Vice President of Reporting and Chief Financial Officer of PharmaNet Development Group, Inc., a drug development services company, and, from June 1995 to February 2002, as Chief Financial Officer and Vice President of Global Technovations, Inc., a manufacturer and marketer of oil analysis instruments and speakers and speaker components. Prior to that, Mr. Natan served in various roles of increasing responsibility with Deloitte & Touche LLP, a global consulting firm. Mr. Natan currently serves as a member of the Board of Directors and Chair of the Audit Committee of Sunshine Biopharma, Inc. (Nasdaq: SBFM), a pharmaceutical and nutritional supplement company, since February 2022. Previously, Mr. Natan has served as a director for the following public companies: Global Technovations, Forcefield Energy, Titan Pharmaceuticals (Nasdaq: TTNP), Vivakor Inc. (Nasdaq: VIVK), NetBrands Corp. (OTC: NBND), and OpGen Inc. (OTC: OPGN), and Cyclacel Pharmaceuticals (Nasdaq: CYCC). Mr. Natan holds a B.A. in Economics from Boston University.",
+ "Served as the Chief Executive Officer of OpGen, Inc., a precision medicine company listed on the Nasdaq (OPGN) since April 11, 2024, where he also servs as a director and board chairman, beginning on March 25, 2024. Mr. Lazar served as the Chief Executive Officer of Titan Pharmaceuticals Inc. listed on the Nasdaq (TTNP) from August 2022 through April 11, 2024, where he also served as a director and board chairman from August 2022 until October 2023. He has also served as the CEO of Custodian Ventures LLC, a company which specializes in assisting distressed public companies through custodianship, since February 2018, and Activist Investing LLC, an actively managed private investment fund, since March 2018. Previously, Mr. Lazar served as Managing Partner at Zenith Partners International Inc., a boutique consulting firm, from July 2012 to April 2018. In his role as Chief Executive Officer of Custodian Ventures LLC, Mr. Lazar has successfully served as a custodian to numerous public companies across a wide range of industries.",
},
{
name: "David Natan",
title: "Director",
contain:
- "David Natan,age 72, currently serves as President and Chief Executive Officer of Natan & Associates, LLC, a consulting firm offering chief financialofficer services to public and private companies in a variety of industries, since 2007. Mr. Natan previously served as a Director of the Company fromNovember 2023 to February 2025. From February 2010 to May 2020, Mr. Natan served as Chief Executive Officer of ForceField Energy, Inc.(OTCMKTS: FNRG), a company focused on the solar industry and LED lighting products. From February 2002 to November 2007, Mr. Natan served asExecutive Vice President of Reporting and Chief Financial Officer of PharmaNet Development Group, Inc., a drug development services company, and,from June 1995 to February 2002, as Chief Financial Officer and Vice President of Global Technovations, Inc., a manufacturer and marketer of oil analysisinstruments and speakers and speaker components. Prior to that, Mr. Natan served in various roles of increasing responsibility with Deloitte & Touche LLP,a global consulting firm. Mr. Natan currently serves as a member of the Board of Directors and Chair of the Audit Committee of Sunshine Biopharma, Inc.(Nasdaq: SBFM), a pharmaceutical and nutritional supplement company, since February 2022. Previously, Mr. Natan has served as a director for thefollowing public companies: Global Technovations, Forcefield Energy, Titan Pharmaceuticals (Nasdaq: TTNP), Vivakor Inc. (Nasdaq: VIVK), NetBrandsCorp. (OTC: NBND), and OpGen Inc. (OTC: OPGN), and Cyclacel Pharmaceuticals (Nasdaq: CYCC). Mr. Natan holds a B.A. in Economics from Boston University.",
+ "Currently serves as President and Chief Executive Officer of Natan & Associates, LLC, a consulting firm offering chief financial officer services to public and private companies in a variety of industries, since 2007. Mr. Natan previously served as a Director of the Company from November 2023 to February 2025. From February 2010 to May 2020, Mr. Natan served as Chief Executive Officer of ForceField Energy, Inc. (OTCMKTS: FNRG), a company focused on the solar industry and LED lighting products. From February 2002 to November 2007, Mr. Natan served as Executive Vice President of Reporting and Chief Financial Officer of PharmaNet Development Group, Inc., a drug development services company, and, from June 1995 to February 2002, as Chief Financial Officer and Vice President of Global Technovations, Inc., a manufacturer and marketer of oil analysis instruments and speakers and speaker components. Prior to that, Mr. Natan served in various roles of increasing responsibility with Deloitte & Touche LLP, a global consulting firm. Mr. Natan currently serves as a member of the Board of Directors and Chair of the Audit Committee of Sunshine Biopharma, Inc. (Nasdaq: SBFM), a pharmaceutical and nutritional supplement company, since February 2022. Previously, Mr. Natan has served as a director for the following public companies: Global Technovations, Forcefield Energy, Titan Pharmaceuticals (Nasdaq: TTNP), Vivakor Inc. (Nasdaq: VIVK), NetBrands Corp. (OTC: NBND), and OpGen Inc. (OTC: OPGN), and Cyclacel Pharmaceuticals (Nasdaq: CYCC). Mr. Natan holds a B.A. in Economics from Boston University.",
},
{
name: "Chan Oi Fat",
From afec6b8ef19ce4adc0b86303f5b47c2a6aaf5898 Mon Sep 17 00:00:00 2001
From: wangyifeng <812766448@qq.com>
Date: Sat, 31 May 2025 00:09:19 +0800
Subject: [PATCH 02/34] =?UTF-8?q?=E8=A7=A3=E5=86=B3=E5=9B=BE=E8=A1=A8y?=
=?UTF-8?q?=E8=BD=B4=E7=A7=BB=E5=8A=A8=E5=88=B0=E5=8F=B3=E4=BE=A7=EF=BC=8C?=
=?UTF-8?q?=E4=BC=9A=E5=9C=A8=E7=A7=BB=E5=8A=A8=E7=AB=AF=E8=A2=AB=E9=81=AE?=
=?UTF-8?q?=E6=8C=A1=E4=B8=80=E9=83=A8=E5=88=86=E7=9A=84=E9=97=AE=E9=A2=98?=
=?UTF-8?q?=EF=BC=9B=E8=A7=A3=E5=86=B3=E8=AE=A1=E7=AE=97=E6=9C=80=E5=A4=A7?=
=?UTF-8?q?=E6=97=A5=E6=9C=9F=E6=9C=80=E8=BF=91=E5=89=8D=E4=B8=80=E5=A4=A9?=
=?UTF-8?q?=E6=9C=89=E6=95=B0=E6=8D=AE=E7=9A=84=E6=97=A5=E6=9C=9F=E6=97=B6?=
=?UTF-8?q?=EF=BC=8C=E5=A6=82=E6=9E=9C=E5=BD=93=E5=A4=A9=E6=AD=A3=E5=A5=BD?=
=?UTF-8?q?=E6=B2=A1=E6=95=B0=E6=8D=AE=E5=8F=88=E6=98=AF=E6=9C=80=E5=90=8E?=
=?UTF-8?q?=E4=B8=80=E5=A4=A9=EF=BC=8C=E4=B8=B4=E7=95=8C=E5=80=BC=E4=BC=9A?=
=?UTF-8?q?=E6=8A=A5=E9=94=99=E7=9A=84=E9=97=AE=E9=A2=98?=
MIME-Version: 1.0
Content-Type: text/plain; charset=UTF-8
Content-Transfer-Encoding: 8bit
---
src/components/customEcharts/size1920/index.vue | 14 +++++++++-----
src/components/customEcharts/size375/index.vue | 14 +++++++++-----
2 files changed, 18 insertions(+), 10 deletions(-)
diff --git a/src/components/customEcharts/size1920/index.vue b/src/components/customEcharts/size1920/index.vue
index 1708411..13edb98 100644
--- a/src/components/customEcharts/size1920/index.vue
+++ b/src/components/customEcharts/size1920/index.vue
@@ -84,6 +84,10 @@ const initEcharts = (data) => {
// title: {
// text: 'FiEE, Inc. Stock Price History',
// },
+ grid: {
+ left: '8%', // 或 '2%'，根据实际情况调整
+ right: '12%', // 给右侧y轴留空间，数值可根据y轴label宽度调整
+ },
tooltip: {
trigger: 'axis',
axisPointer: {
@@ -326,15 +330,15 @@ function findClosestDateIndexDescLeft(data, targetDateStr) {
let left = 0,
right = data.length - 1
const target = new Date(targetDateStr).getTime()
- let res = -1 // 默认返回-1（找不到）
+ let res = -1
while (left <= right) {
const mid = Math.floor((left + right) / 2)
const midTime = new Date(data[mid].date).getTime()
- if (midTime < target) {
- right = mid - 1 // 向左搜索，因为我们要找的是小于等于目标日期的最近一天
+ if (midTime > target) {
+ left = mid + 1 // mid 比目标新，往更旧的方向找
} else {
- res = mid // 记录当前找到的索引
- left = mid + 1 // 向右搜索，因为更早的日期在数组后面
+ res = mid // mid <= target，记录下来，继续往更新的方向找
+ right = mid - 1
}
}
return res
diff --git a/src/components/customEcharts/size375/index.vue b/src/components/customEcharts/size375/index.vue
index dc53cd4..ed22a10 100644
--- a/src/components/customEcharts/size375/index.vue
+++ b/src/components/customEcharts/size375/index.vue
@@ -84,6 +84,10 @@ const initEcharts = (data) => {
// title: {
// text: 'FiEE, Inc. Stock Price History',
// },
+ grid: {
+ left: '8%', // 或 '2%'，根据实际情况调整
+ right: '15%', // 给右侧y轴留空间，数值可根据y轴label宽度调整
+ },
tooltip: {
trigger: 'axis',
axisPointer: {
@@ -327,15 +331,15 @@ function findClosestDateIndexDescLeft(data, targetDateStr) {
let left = 0,
right = data.length - 1
const target = new Date(targetDateStr).getTime()
- let res = -1 // 默认返回-1（找不到）
+ let res = -1
while (left <= right) {
const mid = Math.floor((left + right) / 2)
const midTime = new Date(data[mid].date).getTime()
- if (midTime < target) {
- right = mid - 1 // 向左搜索，因为我们要找的是小于等于目标日期的最近一天
+ if (midTime > target) {
+ left = mid + 1 // mid 比目标新，往更旧的方向找
} else {
- res = mid // 记录当前找到的索引
- left = mid + 1 // 向右搜索，因为更早的日期在数组后面
+ res = mid // mid <= target，记录下来，继续往更新的方向找
+ right = mid - 1
}
}
return res
From ed85bc2771d54e728b7a719dc07a427a3ba320b3 Mon Sep 17 00:00:00 2001
From: =?UTF-8?q?=E9=BD=90=E6=96=8C?= <1134087124@qq.com>
Date: Sat, 31 May 2025 00:23:06 +0800
Subject: [PATCH 03/34] =?UTF-8?q?=E6=9B=B4=E6=96=B0=E5=A7=94=E5=91=98?=
=?UTF-8?q?=E4=BC=9A=E8=A7=92=E8=89=B2=E7=9A=84=E6=B2=BB=E7=90=86=E8=81=8C?=
=?UTF-8?q?=E5=8A=A1=EF=BC=8C=E5=B0=86=E2=80=9CChair=E2=80=9D=E6=9B=B4?=
=?UTF-8?q?=E6=94=B9=E4=B8=BA=E2=80=9CMember=E2=80=9D=EF=BC=8C=E5=B9=B6?=
=?UTF-8?q?=E5=9C=A8=E5=85=B6=E4=BB=96=E8=A7=92=E8=89=B2=E4=B8=AD=E8=BF=9B?=
=?UTF-8?q?=E8=A1=8C=E7=9B=B8=E5=BA=94=E8=B0=83=E6=95=B4=EF=BC=8C=E4=BB=A5?=
=?UTF-8?q?=E7=A1=AE=E4=BF=9D=E8=A7=92=E8=89=B2=E7=9A=84=E4=B8=80=E8=87=B4?=
=?UTF-8?q?=E6=80=A7=E5=92=8C=E5=87=86=E7=A1=AE=E6=80=A7=E3=80=82?=
MIME-Version: 1.0
Content-Type: text/plain; charset=UTF-8
Content-Transfer-Encoding: 8bit
---
src/views/CommitteeAppointment/size1440/index.vue | 4 ++--
src/views/CommitteeAppointment/size1920/index.vue | 4 ++--
src/views/CommitteeAppointment/size375/index.vue | 4 ++--
src/views/CommitteeAppointment/size768/index.vue | 4 ++--
4 files changed, 8 insertions(+), 8 deletions(-)
diff --git a/src/views/CommitteeAppointment/size1440/index.vue b/src/views/CommitteeAppointment/size1440/index.vue
index 122703b..501da91 100644
--- a/src/views/CommitteeAppointment/size1440/index.vue
+++ b/src/views/CommitteeAppointment/size1440/index.vue
@@ -131,7 +131,7 @@ const committeeRoles = {
"Hu Bin": {
Audit: "Member",
Compensation: "Member",
- Governance: "Chair",
+ Governance: "Member",
},
"David Natan": {
Audit: "Chair",
@@ -141,7 +141,7 @@ const committeeRoles = {
"Chan Oi Fat": {
Audit: "Member",
Compensation: "Chair",
- Governance: "Member",
+ Governance: "Chair",
},
};
diff --git a/src/views/CommitteeAppointment/size1920/index.vue b/src/views/CommitteeAppointment/size1920/index.vue
index 17ba6be..8258164 100644
--- a/src/views/CommitteeAppointment/size1920/index.vue
+++ b/src/views/CommitteeAppointment/size1920/index.vue
@@ -129,7 +129,7 @@ const committeeRoles = {
"Hu Bin": {
Audit: "Member",
Compensation: "Member",
- Governance: "Chair",
+ Governance: "Member",
},
"David Natan": {
Audit: "Chair",
@@ -139,7 +139,7 @@ const committeeRoles = {
"Chan Oi Fat": {
Audit: "Member",
Compensation: "Chair",
- Governance: "Member",
+ Governance: "Chair",
},
};
diff --git a/src/views/CommitteeAppointment/size375/index.vue b/src/views/CommitteeAppointment/size375/index.vue
index eb0c6d2..c6b32fb 100644
--- a/src/views/CommitteeAppointment/size375/index.vue
+++ b/src/views/CommitteeAppointment/size375/index.vue
@@ -84,7 +84,7 @@ const committeeRoles = {
"Hu Bin": {
Audit: "Member",
Compensation: "Member",
- Governance: "Chair",
+ Governance: "Member",
},
"David Natan": {
Audit: "Chair",
@@ -94,7 +94,7 @@ const committeeRoles = {
"Chan Oi Fat": {
Audit: "Member",
Compensation: "Chair",
- Governance: "Member",
+ Governance: "Chair",
},
};
diff --git a/src/views/CommitteeAppointment/size768/index.vue b/src/views/CommitteeAppointment/size768/index.vue
index eb0c6d2..c6b32fb 100644
--- a/src/views/CommitteeAppointment/size768/index.vue
+++ b/src/views/CommitteeAppointment/size768/index.vue
@@ -84,7 +84,7 @@ const committeeRoles = {
"Hu Bin": {
Audit: "Member",
Compensation: "Member",
- Governance: "Chair",
+ Governance: "Member",
},
"David Natan": {
Audit: "Chair",
@@ -94,7 +94,7 @@ const committeeRoles = {
"Chan Oi Fat": {
Audit: "Member",
Compensation: "Chair",
- Governance: "Member",
+ Governance: "Chair",
},
};
From 1fbda73a3f5e1836fb7957b9e4936ae2723a0de6 Mon Sep 17 00:00:00 2001
From: =?UTF-8?q?=E9=BD=90=E6=96=8C?= <1134087124@qq.com>
Date: Sat, 31 May 2025 00:40:22 +0800
Subject: [PATCH 04/34] =?UTF-8?q?=E6=9B=B4=E6=96=B0=20secFiles.js=20?=
=?UTF-8?q?=E6=96=87=E4=BB=B6=EF=BC=8C=E6=B7=BB=E5=8A=A0=E5=A4=9A=E4=B8=AA?=
=?UTF-8?q?=20FORM=204=20=E7=9A=84=E6=96=87=E4=BB=B6=E4=BF=A1=E6=81=AF?=
=?UTF-8?q?=EF=BC=8C=E5=B9=B6=E5=9C=A8=20en.js=20=E6=96=87=E4=BB=B6?=
=?UTF-8?q?=E4=B8=AD=E6=9B=B4=E6=AD=A3=E7=AE=A1=E7=90=86=E5=B1=82=E6=88=90?=
=?UTF-8?q?=E5=91=98=E7=9A=84=E5=90=8D=E7=A7=B0=E4=B8=BA=E2=80=9CLi=20Wai?=
=?UTF-8?q?=20Chung=E2=80=9D=E3=80=82?=
MIME-Version: 1.0
Content-Type: text/plain; charset=UTF-8
Content-Transfer-Encoding: 8bit
---
src/dict/secFiles.js | 36 ++++++++++++++++++++++++++++++++++++
src/locales/en.js | 2 +-
2 files changed, 37 insertions(+), 1 deletion(-)
diff --git a/src/dict/secFiles.js b/src/dict/secFiles.js
index 8a6dc39..241eb7b 100644
--- a/src/dict/secFiles.js
+++ b/src/dict/secFiles.js
@@ -205,6 +205,42 @@ export const fileList = [
],
"idx": 8
},
+ {
+ "filingDate": "2025-05-13",
+ "form": "4",
+ "description": "FORM 4",
+ "formDescription": "Statement of changes in beneficial ownership of securities",
+ "fileLink": "https://www.sec.gov/Archives/edgar/data/1467761/000182912625003622/xslF345X05/ownership.xml",
+ "dataFiles": [],
+ "idx": -1
+ },
+ {
+ "filingDate": "2025-05-13",
+ "form": "4",
+ "description": "FORM 4",
+ "formDescription": "Statement of changes in beneficial ownership of securities",
+ "fileLink": "https://www.sec.gov/Archives/edgar/data/1467761/000182912625003622/ownership.xml",
+ "dataFiles": [],
+ "idx": -2
+ },
+ {
+ "filingDate": "2025-05-13",
+ "form": "4",
+ "description": "FORM 4",
+ "formDescription": "Statement of changes in beneficial ownership of securities",
+ "fileLink": "https://www.sec.gov/Archives/edgar/data/1467761/000182912625003621/xslF345X05/ownership.xml",
+ "dataFiles": [],
+ "idx": -3
+ },
+ {
+ "filingDate": "2025-05-13",
+ "form": "4",
+ "description": "FORM 4",
+ "formDescription": "Statement of changes in beneficial ownership of securities",
+ "fileLink": "https://www.sec.gov/Archives/edgar/data/1467761/000182912625003621/ownership.xml",
+ "dataFiles": [],
+ "idx": -4
+ },
{
"filingDate": "2025-05-13",
"form": "SCHEDULE 13D/A",
diff --git a/src/locales/en.js b/src/locales/en.js
index 94c6762..ee61da6 100644
--- a/src/locales/en.js
+++ b/src/locales/en.js
@@ -707,7 +707,7 @@ export default {
// 管理
MANAGEMENT: {
ONE: {
- TITLE: "Wai Chung Li",
+ TITLE: "Li Wai Chung",
TITLETWO: "Chief Executive Officer",
CONTENT:
"Mr. Li is our Chief Executive Officer. Mr. Li has extensive experience in accounting, corporate management and finance management. His role encompasses the oversight of our daily business operations and plays a vital part in the overall management of our Group.With a track record spanning prestigious roles at Deloitte China, Shanghai Prime Machinery Company Limited, Lens Technology Co., Ltd., and more, Mr. Li brings invaluable expertise to our team.",
From 07ff81ef666aeb4a8ffc5289ef349903305c55f5 Mon Sep 17 00:00:00 2001
From: =?UTF-8?q?=E9=BD=90=E6=96=8C?= <1134087124@qq.com>
Date: Sat, 31 May 2025 00:50:40 +0800
Subject: [PATCH 05/34] fixfile
---
.../FiEE, Inc._Audit Committee Charter.pdf | Bin 223626 -> 249299 bytes
1 file changed, 0 insertions(+), 0 deletions(-)
diff --git a/src/assets/file/FiEE, Inc._Audit Committee Charter.pdf b/src/assets/file/FiEE, Inc._Audit Committee Charter.pdf
index e78ec9b548ae59f74d6a1c1dfe5eb43326e2b090..d1ee8e52c2f83169d385cbe33e9c544d46f00cad 100644
GIT binary patch
delta 70900
zcmZsCbx>bTvnFoA-QC^Y-7UCFaQ8rf1HoN>xCD21f@^Shcb8znW%IswZ|!$?x9U_)
zpPBBSe&(NZ>Unx1=aA+yQQ`%#eXQw7Sw6eFdYHRwxLR1KJ2|Sa?~us=8WOTDV#`np?P$^6_vbBsWsBvH!a+%|XicU!KyOq-=cuHOEED&i0Q5
z5_84`1%RWWv9Xf=eg4TO^O=o}l#LBk7p4b#1P1^vUUp$&Bm_5iR|``IB!sV7O+q8F
zj6Yo-U^{@)f-kvltuz>4t#d05o9xHwdB0tJ*MV3?Un#9XHMOl{tpjZM(eO#(hPWrurF!_AQ$27JJUn;~CoRfHjH8e1@=R*6AP3QzyJ3X2U`wW5q|z8vR!|
z?XIriiu($sw`I9t;c1L{AtCThTjM`Itqvde==wg`Se-f@j^=j3k%#ckC)ij`fbrd=
zp#WR*DQKp$owf9BE7rB0+JGRZ3x{8w>75ZnlbtMPrQ4^l<_ju?;h@6m*NEtk_K(}8
z#yXXrK%1Fg8B$}&$kO3^#o*0uQE%Wqi!@-CPU>i-T21HnE^hw%jUR{_@9?TWVcNiI
z7Z_(bzv`}syuLFh5l1o_%O=6y?hqN)%;d{1
zx`HPWq=#8@OzHI75RaV(^O1|$^@0qkHbA?pYLC0$v7_)Oy5;fSx2Ov+x<8$cheT1Z
zo&I@wur%Kal=*EofQf4%e`^Lp6&?hPfE)d*YylGj
zAhlJdhhFfY9^%X|*sJ&nagxdCo-V1%Te|PL%9oU|@(+bxE_gp#j_HCvVM!56m#&x4
z!v27tFe%nt8_G7aXem8$h(nz9TM8vk!BsWDbYoOFfJ0PY&O55%RKsvA$N
zu6sFS&ZbJ|mtbT&F_cadTdTDK8Z-Qr$X>}vUaZ%J~q!9z};Poa36_OY)@i9J`W
zw?B09dnD5l9SaZfND)LKIcqP$Mg(+@>>`Ex9fUC~sZuVsr_3iCgE?djaza%KZariV
zf3KWcf%fukybgpv0Z@LhUc-5?=hWv?*EnlDX4j~A1Ic2|RtG6Hspu1`WjT;TLdsw>P|duPyldP!qDcYLX_!
zC)u=8UERNOa6_bNQVxY|9nzGO7Dd23@m`=e(`1zV^-cKTwMS13s3&7n1F
zGm#xc&r@~m!pE8VBZ^oyi;mbrQtJtA9WiI{1i1rARrLs!aLGr6l4H}T=uMhM{<|xL
z$1E3xdfax^eJ$i~v1t_1A>Rg;o5(rRYo8&uG>_PRfW_{#!HMG9T`#;e_Lupxc$w9{
z@?@}!$Jk=MY6y2v@;D7Pe!;A1NOru00fL901e#-<2DMv>y|U2b4R6$s$%SLtbR{8*
z)VWc+^0x|2uPXr!>rBl8@X;{#5C61OWx*f|WQI$gb81pE5=`>-eFQdR
z9i0qlU@GOD5YARz+~oF#24Oj-C_vM=8;kxBi~Gj#B&>RyBwwm;VO&kB_e_kYW!;||gC#O9eg+QuB*qEN44c)C}J@91qUVO@yPv)K|aLfuJpz1a^ipNPKChvG?FSUn7KIKqtR`
zmo3t+$g!v2zaY<9u9W6?m89kyDJJYxN=Oe$6y_{`wFjK
z{4VmmoeXnJs+dN%yqlSWG&0X0SmSmrOqqhFN79A1iMW$o_
zfYGmd=ORb?w==Dj71KQSJONWh{b7xWQ^t3SkjXpBGg5o`E|}IFUe}g1e!mvn>ire`
zQ=;EErmNUXqfPGJw2{bSjL55Ttvbz*l3mY=g2H4GQk6uJR{NNXrjQ2g4BLzR@TPGJ
zp*ml+Sc_tG$5&yQGg7|AI2v%jF;tn@1F-i!cWzYFOdfRSn3R)&rCHu>RQAP{-bXBi
zD!q^8L+iB9RtpniL9%H0HTcKB^=D#FQq}`S+12ZbvJrE50rOUBYII$EPAgT}TYXXAS@pl+v?
z`gJif-;NSa*J{`0a6E~e+nQk
zKJLGFneOS{Hf*L3%EunTL2g&D_8X5PV&IJa5!-AkroM-CjjkLmmK?+-F8U{=4E~Y`
zK0{b3UUzY(xZdZiF1fIRkaVvS(9v*kO|Z*}mJsA-I9GciQqQ@9Mf{An%yz6fftQKFz+bMCIlS|=+dzWwY*M(JDfC{}BJ%)@dA_O$la&+Ew!y^Lpe
zPAQSRSHaSZhii!R9|m09{vT2~`}-6=>NSQU{od;P@$+G=Ms?{}FLDPsz|k`UFmi7M@xyB}-yWr#jc5-1-+PiKKm;!Yp&
z1LLdD%bv
ze3P4?PunWYb96StfF0rv)I}-9T5zT@0_)@v<)6`j-;_)?
zh{&jdPn{8XS;t+$_Dl2AyqW!ZxMpD@NIt-HIJXls=gJP}){voqz}O7iH{AOBLfEhK
z)3z56ry_AQE9aa}vsawqxPD-eHJveH>;ka`3e
z!ssp>3zbbKUwG6_fFF?A4pP;^qa*fY?AG?Ny!+>`|NuBiyq_OmTdt
z{hJYp+;d<*WO6G_)B8eJ4^AgqF^z({eK5xS`*NBO29I8xFNh`Di5><`=Ue#uM6FzQ
zn@H5?VT!d7wPYcT-A*bC8EL`M&WK{-WvMre6TS_H!dr?f01qilw6qqU8Wd#Q@wIIG
z!)Kc=8ikNrnJdj&Oy`S~HecZ2y&I(COgx3ENBAAa+UBBWi0We>Jw3Isxdnz-&scxw
zCZN}uJJ$Jy!fv@oz2!@x^pMR@$TM5&UgRS`JjFEW({P2an_i_SyKnb@UF`spKJ?m-
zJvQj1G$|au0jjny_b0R6Juk2~-`a`*nQ93IF`l^Jd%0bFh7|MQ=)`ghJQcMu6kt5Q
z*<>-DE&~kKMWC~wYCIp;tP<^?rIsYIlfPiSM7=Wv7`PivgN!sq5E2-R4B&F2+9}#A
zR1v!CTnU
zk{H(>Sd&FO|AD5$ZDnrV0Jk=zPi!W|2iXcy6U+)-T7TxDWcLY;T+!mJI%;4fY1dx6
zaCbhG8P8x?Yrsd4^{rsSI7;(((q=CD{3)h-hr%}GnkNd8U=eR+nI)ML1R|54*G@*y
zKP7F)7%pmsd$a52l^QiVK){58C!=Po$qobPIfYYV4f$;LxK=N>L;buwc0H-9EE^&D
zF>QGx=Abh|y+Qx5IsTz-UrC;ylQU2rh!G8MThw2+PVYu49c?+%DGr1RhRvaPR-X;`*qPLFZ-sZX#-iIctPT
z7{66#D#p7Na)}og4W^FiUMaLqaXfd}-%0si%+hbH=Ul?#2U+3ml?cAfPuk6&)B*oy&KZmFq6aDUSyq8Zv
zaaR(0rD{X);lGu!#>=xo8)JS#`m+%O3a`>n)=_<
zaI}a8%*&5SkG{=MBz(i>K}VAw^dXgR6y?fPtCy8Ib+T-ZRMV%bbS
zC*
z^?^0&&mrbye6YP9#Yj$mRsuja8+}5WQ&{Kk-%MC?`nTyzVC~kV-qYDTDO;fwD!PQR
z9k3-i_{3JHBguwM8JN3-a)
zH#L$zy(C9_uF9uAyUZ)v60;^#h@9DVp?c8Ly;ffnsm0^Y?spR%8JPf5>WuDPGcwX0
z?mKM){p3y4ldRH#iHHmkv$yqIBMu}NPI@#)*-4-%Cxo7OttEUWuGfjB=sODvr7n4Y9=grcD!qdSkO
zNNFVWaO4DxaaZ)mJY(Jh?0AKjq}59;&v0-@MNGy+>Tn!{O+e)0xfx+uUe%N=G|y0g
zlTTgoRKXKs2;sRwKOX~|eUWana9Yn{T;Hc9D_h0MBf1OhIl_Ck`F?O^uZoBubf{QBrF9lHWuy}ErecTgBEu)ZN)iW
z`RZ96^Dv&r;khFhWnyM)Ppcl487DL?CC%W3;v4(-^USBDdomp5g5yW&Cae1o`N93G
zMD(oWB;gt~%YCG%OIv!pdk?~z(GO{4v^I{J}oj1olT$l(=ZMgxInhX-mQL5
zup6|hEr`_$p>{x3_#QzmNEt^6=*4^bQiDm`Fc_WfeN?7MtPSr*oy|njsaBp*#CnKFIiSM*~|^R%=E3GOQJ6D~_09iWSk5*f81|0PPWPo2
zijM`YDRf^>loxi&Nc9fO!3-BgSoL=#?Fh|#Zh>8+2P@|$9NFo;UL}onfwP?n^ogU{
zuP6I(=n5+B7Rq+n!AoENhDB~ZDuDW+d6>H4evN`sj%Eh;kCe|XnY5TUT^GsxoJq!W
z9RZ)j&gWN%5p`kh2eDi;qIoVASKN1G0Zk#&$ZtZ&cs<&Uew`-YY4GGNQLVbaawisE
z%EA)(j|u#8q?k)H4xSm_
z`D$*v9_itfq*(4+5#Km-Vu%&@+qsdsdapz)EOLo!4|h*-1G@j)e^=JX7kK%!vyby2$%=QM-%|^iX_3<#u?9
z6-;^Azf447{j)C^o*KnD(XnNnk+*$|6{{c_G$^h07|q+sgY=av8w;M>yz&Fq?5FJ=
zs8A6@QC$EdHz{3Bt=57
zaQxzAW{ZUI&&0ompdcuL4DW9WI8Zj8JUA~%O$?Lpzldq=zX|?L`48p%-+{a!0(@D}
zFI+4T3*j_Kj^Gm(9~aj@+5gjtjTK~w%L(z9xHiP41U2KLg7EN>K)yKeAU^_JaQ6Sb
zBOB-)4+eBdKnlyp^>2Y7ZTuV12O$#3n&2N`lDusHW@h_sQx{K
z|KY_4a>2p;2LgzX=o2XOZ~k#%5(suy&<+6=79aP&B>sN}{9SRuIfGzl`|mh#E)YMF
zDg-~kM}dDmWPL&_t)33f8~e2
z@79O=@T0^zU$ZQ|;$sa5=^k
zCu-2h?ooFGaqJv*Jj$^M0wOX4>N%oGyGwlGMH-+vEYp@h0w+t}uS3oIdY{N(DQB}p
z%l2qJKo~^wVLH|5s0P`8jUjFE@)vL|^^UILo=!IANHDCB?W>yeq
zjj?d^x4kfh`6lPBtV=W-LNrWzl(W8^C!6aXR%P7v<;N8Y=30MffJ+yURA@A$o`#%8
zrLM4RlRo3+i3-bEno4b_&=`0+v}=8tMx-TM9mF$72q>ezX|?>WsJ-^+kq%;%IQcV%
zhh(w$2R{L}K;#-VqQfC$jo*%-8bzXtr}fgW*6~N?E~pa!AZpD~o=00e$p%G4nlZaw
zhaxzOvIH%&FvP+I2vnv*%ehj=OSa@6Iup||?W5-S1l7Dtid+>KzZ*!px=}%GoG9e;Q4{9NnU>hRVD3ilbZpQHQC?
zrKXmM_{*CyqHTbUAXyYELPnZ&-PAopvn-K>-HpNWO>Ee^}kOQt%3ddR`H;kOYOR3Z54LUTV
zBVNs_MPP_YAqSFQR#>>w9fNHqJKD@%xHqN
znK|NVd(|LfZdVpTU#F$TKl%pO{=`CU(sCm{Qd%k(P|%rL(ozhs)6&4vKX+$urE9StbKa>2=Rn=C**5h&q}^N~onQ9tp*Xb9Wg15tUygzzA5JET
zdd5rZ|52*XHBnjmP$iDcKFe;_i===OJu^?@jm}T$gn{GGbSs%(|AR{mWme>BNm8J`
zl!i$T7`=vJBalOwfFrh`IT}-M6SaY
z{!$$MUM)p})4$Xx&+IE)jqSZwWud8d7O$lWDgXMl_4jr2Kw-$_RSati9SwvMUs{84
zwt#)JwU+c$c=E!SJVZHu)_tWAS*@U?L9**p;527%cWT9ViSHRBCb<6aMz`U|i5lf_
zML`oaBTL1w(CJr;DX^i|WX*=G^;yG}&GUtLFI+GQ%%k+ru}3F-Xzs$W6ay1>1M35=
zp81g^z;O-^I4ACJr61LgHMO}wt_RT4N`!w=yG599Zmz%&c~=>}!TWmqgK^3-@dt+G
z)$eUX>&XH-Ev%Yqw+F&FAa@zWLFY3C4OrV>pbDy6nZkWxM(GbP8ZgFm8ERm>hfgPU
z7`v&+nq{5eRlCD|%_@z~l2|p}C05xhwR6T?^J3*nFdf9JM{3m6o%^T5
z;?+=0(FJz)$y~2S+`p*~bOu7eCp`{AF*#3vD>J!8gqie;h>sah`U1Z_jo~LXfA4R?lE?z
zN_>e;p)T-LLy{-Uk+Y09#lR#ud>|f`Gbz`MH}jX+zAn@V(VWzh*mGkBj_2GQwwt!}`tE-;cQVr&(&CM+y^N(EkB
zQwrh~J<(dbTDi;wJEDPrqbN3$y$w$NNfVh6sl$q)vkn>>)l2nhWzk7WECB2pKke0`
zH1`%X`!<47HEsbHmkJUzNF)4wXd>VX!w_hCZly~CxoCL{Id66$dWEOWuo~AKzyM7L
zd1>jVnMELW1zv3&+I4K80>gcXbSZDa`TViEo?a_*i=nnE%OT3X
zw7A6>%~-Qtmf1~idk*!51(*zqnFCp9CI*Ky1v$8c*e7ijm+n*J`@we*!3Nr6IPgE~
z1RnpoC}kx8kqOC+`sDKQ;!s4G+lXxWI26g4zcaCzL~MeHlv
z)YP33-6$kwC!J3i{4CUcDqbdnj%RSt}~C*TtxxPab?)W)`kO7yrZ8aq5=((gt=BtMGlS7HW&
z8X93obuyJ`6VvR%7!Y%P$o%xkjw3!T5KFgV!+ua*5Z8I1?kc$y%zs%{LLiS^xFH%u
zk9n(^)zv$rPro?w1&Rt>k+Pz_=!dr;a?v(+^*2o`Tk3u&X@<$@l7?H;Gl-QH2aI+j
zL`nD?h(1v#C#UaDjT`Q)?1~MlrqJSvn;YK+x-4*fFTjLy$T8|HfNBfOp=+GVox!vf
z!M=~;8IQS}>$|Mbdi){5MfCLBr_0)v7i+b;#l0x5hp#kW92m^MP6)7}$X!k>j2>j&
zvNtNS6+|{aAII9K(PnER__oKKUthqbi5o*0pEx!v!a{xVtWG`%=8{?j7^#?rwT>cK
zQnYHQd#mmQ%KOdkYGAb}uoY&SZk?+@Y#FwE#pLFQ`{|{5ZyCHcO85fPQ)J()oBU_L6L>&<6wJFD=Qas@3*x4QMlO2Ehf^}@spljF+;5wL?hxKTK3XRg8Ve5
z-h88!{_U5c=7=>?K^yb$QRqF>o18L@UzAcYvIAJCT)4}dDc?)E+cYE0E8O(I)A=Cc
zS~RVQsQ`XW9+w`-I&ec6JUt~}5h_KSA#Z#%gUh6r-;NP}$)Xn4AZ#}xwv!m{PLqeV
zU2BYmGRE>iUGz0+DlbKG2uMrHfs2PfAem^sCwqfN@
z!6iRcp|VW~L4>_7Qn{eZ-uwKtpB_c4AD4?4CW)yWiQ5&OKYoSDkjg@1_;WAz^)xii
zlZ|-kKz~%?CgOK_GwuRw41M%Z#;jRSbWbaKCEfBta0F&Sl}T!FG?+E!^!HS^BTZ_&
z?Os6pXPr>KlnSap-Kx9%|rCsV^b769MiN#l^DKt0usy7De-Sa50&3zJVh?H4F2V4oQYZDALAl
zuaUNd%K1m?a6XD)M|_sDL8Y---9s{CXU%IVbkU~cn4TI{PxabgZJq}yRi+Ef)7!Aw
zuXt?wDApz?gyvg=2XlfJgB&oFDjImfl~oMzJ7hgpqp8@1Yng`2r%4)$^&G*rnSHDag3<|SUT*=i<}?m^mYCNo=$ctKp0Lg7HsOt|1)o7^nu3ua75i=UV$
zc<=ATTaBbb-Eg9^$jrIC+$uDX#o;jV-jnzv0k*+93VqE5@RtkA;QNuVcs~uKAXPr=
zDVnN`YCXm)wvE)2rPre-GMSU53zaEYNtI+{Z{@i~`{6(i2wMDZ+@$SCqKbhhOANu#
zBQJR$11n)+5Ue%R^BMOi`D>(N5ihH%ZBjAg7C=kTxkq(v;enGcdJKLEVQKodn~_B2
zEbNG5oG)O28tgfWxayorGJvVGn3T1*L{D;Lcd_#BNy>Tr`5CFic92U@9{n>hjQ6fx&Bpjq
zYiM(C|8#)(kphP6EO6C~sP^32vkMvc`m8D|r>#53Ykgk5N(@%SHb%K}0e+kl{URoE
zOrFL~Ir2TIof!Jfy4m@3pyQHPivh=NT%@U!E!rTz9F?3jq_u;F%oT{w_6e*1wNRF~
zK7sh4#nSF~Fj6aXpvM<+vD{Bo6Wf+*Bq_MIOl_ygfI2&=1uWi-O~$}DoqUB7Uj4i#
zldTvpM!B5WQcxi5TwNHf-&OJbYpSKFOEtX?#Ndo4d*$vnwo{#81m;A`f;45kNrTW=>z*9v+vvq7(Sl|;a60;<@=D7idMVeL;=r*{@8E2QeL}md+Ksnto-7u
zET0C&Y`^_zBs(jBcXOS7ia@=hNB!h(nld*|oYSksB~&wWb@6L1eyX^|T#CzfwMDZ?
z!MUJg&uC3c6wTJaKBjHJhj}qj*itHrcERIYxpK+eEK-$yf(9MNN%&+)H@%m$06ovt
zYP1yy-V4B^mNeuhhL9062(##O>d1!QqsjBDXRP|H*8-aR?p$rd?-lqL`-)xn%w+D0pSbi;c|%CqDP);b)SOzmeHfnH
zufSH1IbBOl&Q{qxBGpo5Z)+t07#Gu7H9El!K=q`ON0i4WE
z{HwlqS+VC0mm&6O={!#L_%Cmq{3#f8Uv!ZjP?oP=aWJt-EfY@D!8%0hDxb+o
z(7Fc@Zh6^<(!8$iPIUUZ3bWzU!g-zeglN@S(0v~fWCR*5NUP1mvKob84Exm?b44MU
zr0l-hq^uWrQ<`Z`$QAsgvkwd?IlT}3cKpj(p~6eegd`#B2R(}7U_@DMB!f}jA!BE+
zqpw1v2;476Rh*({Xukz8QL)?8Wb>V_R@f$BeUhb4s8mfQ`bM2IQX9bJ>v5^h%6mcb
zF3Y4O6qk$Apv~x=`Q|@pfM0ttLT=>_hh{~8f}P0e-hMSeH|q(W&PXNOZ;W|ykkw%j
zgCM3bBZ6>3m4H?pz@Sp*vyo3$RC~vS2uAJX0oxPLh%*J3BcfEG8LgsKv{jWa0zr5hyE|0Ecc%ObT}!e|r|_Kayr(w
zC~4WE&??vS0^Yrv>?E(KwGt=2aZT*{Qa!i&j<4_wWOFem6}Wv2g(JQz^?(YH^tGOj
z^lwwa_A3!X=YDl8B^2oqJkds{Z=#Im%cpe)_Fr5lyPuQooLh;Ig@F&+?u2HcK@jtF
zRk21OdCN`@UG#Vj#D;c?qy~=`Bb#Zq4EafPjiGX{W>)|_MiW?Ow!F7+qPlN5;!YA?
zJaW!FehH3{S2N@6w;%;~o%(6u9J@T>6pBpn)h-V=`tiileQeNSx~LX(2-S{&a^kPu
zzDWsS9)}RN=b1K0wGiM<&SUYQfqRR!DJEtz)JbI%bFZ*$v|D-3jg9+Uq*TbC(|B(j
zUz-_gV&^rkPVRf+e3M0Iu`9~ISaiu#Sl`hNZN2)ru@HDPnvBsZZLSPBHIZdb4$2d8
z9MR)S5^((#cG?e(j-B>e(O++ANbw2l3H(fO#%~~P_?1i1xY0ja)k}AF?>uzqgSjec
zx13O1pj)a^0vRH**cq|)>i4X;c633sy1}}nlWvpZSpr2rlPVY*kqZd~f3|39#3oy2
zSbla+USut=#BAwU>LLO6{@v7%0xD?O8Cc=w(dDBf{@=1Lv+wf;$>&ca8IuUn=QXk}
z($VwN$&~$3a?fmS?^p
z{vFvHT*Ng0nP3Brh|A*spGNtAnCX8=f0ln+=0RxGSpQ#+S`Snx5eV?{vHf2hwa{2B
z<=+N*@I#VQTD($&t`R7FX!j+>vF6I4JaAuBUsNa?6{E-Nj{uGlIQH*yT6NzNKQUSs
zvx5*}g05q?4^l-w9*lwZj*i!xl9z7Z_Hg6(i<<5?pQnv2p#A-p1OVC%H@h}iK5qX+
z=>P-o#&AYP1B2C`GpFd$23j6ZTiw9h4atZ5)5Te83yE>}>rFL_x}pE;-dXCKrb|Mq
z$BSNiREz2L<;`AqbL#t*6&-W;`xf`r!P1=y{Ksqm5)0ss)~7>O*ztCBFx2h;cH>9z
z@J}DS@5kJm>kil$2G~7pz!Ls8oF&91;FY>15+a`+B>fYv9}GlpAMXLSR$JVJ>e-(K
zKgCvJ)mu8hD?uVn_oLskxc3nI4UF5I`_<-gYxDdbq`CHS_I})a>C~}RZTa%~cui9d
zmL=_v=fb)6#V)h#6S_>K${y>(+WT_hkap9@xu<$qoYb;NbBiA`#tn~l)QA5dpv&3U
z?q}-@rQGou^?vH!w6fAaM)lj*!>V8*H>JV4=*~!2X3KMgYfFbV
z#Jv(lL{Y+T@s3_g8u67b|43{RARPz4MRrd76B)1<$cz!WYkWK9j6kJYFa>KsH{dud
z!x(q!^!1UW4?~$7k&J~FQua}#P)w2EIHfC;wNu&%17*z)iY4DDX)e574Kf3T@f%{m
zFBB%lC*>{(Ptrh|PMTsId>NvEewI&Ez271-lD>|-HcaolJ3+(2EaJp<05tKH3HA4;
zv{viHGK-B8El70`l-`~}Yl*37qpiE5*XQ9qB6tP9Dyp%no@t6JdMwg^kbU#&E277I
zJM*FglnV3dyZXAvzAOVRa`#unSi&I<3Yzzn7e-_-)JkHAK5fQQvw6dbzL0o%ML(0|
zuG;T@IP`}8-c_Rwjz3x+1ey>Mz#&K&=O~E6_VC>77u-kd_tEN_C((&U8I?tH3zvpL
z=z3c#5u-X*>>Y$Vhm(=+2z13prtY7);o`DM1T1eT3kttYCh3TO5@@P~ieY`{Qivy4
zW%rsO+_#Nq#UEl6mLLj8%+d8LD#a3xm2^N%*0%wEnBO8sm4zr30dM4fB$*WSNm&-W
zbPZxne?PX22V+{;*O~k7*t0uz@yyTadGO_}PTh8cl%MnP<`zl{X#Mt3?R+F#wsyVl
zOR-U1)NDjUcC(j{j@ZPVHlzX2OO+$o_`n@HLwdRFJ1
zKi`U}^pgpftEZ?80tA8q7vC6iWd0zDHLdUq*4pI8HOpmM*0E|pQPrl_iz+eHCChq-
z{($Vq{o+j~tb@^VYml#(zsT!P?pO)~QO&WbRo(|KTC?!O0-A*+etJD4d8IyS0K=#(
zLKQR7)Ld5i)}Auob1ke{Y_9(oQ9RM`!-b}d2E-FuN~(sqIFJM1B-KA){(T4$8T%lh
zhv@eSja-ws>MNYzHv^NfMrc8n$qckEKvzQMv{O$Z93sZYbPTgMkgF4nPC+xCx=LPw5~CB0-)4?I>im{}WVn9iCaksXQVDLy
z*KXVhdV`gkbH0xyQfpnHMZea8&DMh}*J-S}&v~
z#bVTmS6k^uVMV`D`}|$wSK8Me0S$KX-c!W6Q9|(B_6cAX%AOY6BUH&F00AXgpFsW&
zRfneRVM4W_;r{rl)u1Je+Q9$yf+bfLS#1pue~qmV7n_OSIX2HJB_)txE%=-&1b1d5
z&p47h8R?ViKsZu-)|i|Xid0O4z>!HFGj)!2;}}BUa5$eW2w~Wlc4Y9*v~<)t@}ztw
z@$@I@9xR}=k@2fQ1t<2tvN(F25g7tFIh
zG|lOOp|oO+K&Np#p)?!JND%7-V~r5{vlp2fb3i2%#tf2G1?(uaN(>|ZlqLC1s}sns
z(u>dBHmCf_WipeW`z$44BL|t3YBcEd}Hgc{%N0j{Z*fC
zf!_q=(p)ior})CE$PKemjx60sg$6l!1BANebM4YAM*DDHte<_$!(Wivaz&sQ8xet@
z%#()a#St}4?GN=YEKRVm#cgqQer`bM_Z@+eI{|e4+*mRfJ=XO!;V;AROnf4t4R|9}
zEnhb9e>ms(ztpDE+!ih_@!xWvdX2gjsLW|~DfMm%=oQKd3b}p090ysjLb`Do+NF$=
z&bShohBiF42B9A@K~M_#*#4HFRgUDhVH2SJh1ZpSs0&*@Z#pv}N;!hS;xY$RaB_ZX
z`X$Ap+rZ13A!jD#I@-uXnE?C1R1(gXOzU4@0h(;?)%f%xAwR~ZJKBhmK%n6!oAO=7
zu7;7kAysXimzJrD#!7(1AQhLaq@7z3k7@&mcVEeIP}A;%AjbT$3$DqtXRsG9*pE?@DFz^@%|O)SY#CJ
zG*d+c=9nR6`?{+{(kcr#5El^^eEYtOE27b_ifzr79!$OIaf5SxA{+(4u&+vecf9c9
z8jLp*qZy_mprS4aaJA6SZ~-A5F3@L3{=t2ds{Wp^zvM1#qh$=SVL7d)6;CT;I>~o-
zPqw@1E>27emGU!?&LREGLHq4em(52xYHnPGmsb2-E@UD|{f4#OG*@1xy5Jy*#=!71
z$4i!@>P=?YSISm81WZQ2JF=Mepbz=iNi`?YyK-?Ugf&}Mtj}kxz@GK<5?X#AqjJLX
z=0Xea#mT?jugm^DhIcI9c~uhk9q3+q(-dfjmjMqGr9($IRKuqS4}k|t*8;RVI28hR
z1Z?RSg5471PF$PJ^`Ym-UbugRmPfk6s9Vj$v(CR+OK9QJgxe(m6^gZpEaeWDxTVr|
zWO7&Ie>=UtVi=5)jB|{QdeOhnqOP{n1U!57>b&|A!;f|bxh!pOd-ODGIS@DKevSC5
zjXFbxldT=ISgfNJ?m&?oCHVIu-9-Ait0mSHiAfzu2<=zdAa_Bgm3H0;7mn3(ess00
z9)W9GOp_}`0s^xzKuYHF*};M}xOs2x8(D7hj~_5^=J8p!(F_gPc1X?>Rie|Nn;6P;
zzB}bQbHmeIj*$(zyD;*@tDjd0y(GGF7I^L{JoYmyBR}BG7ei~_@lZ_lw&T}D`dNj3
z5%hV^`dT4L?Am6?(Jv6^t_-~7+YYa~0y_6OrauJ}-GEQ8X7S$O$4H1!ZKs6w
z7Dx{Dccgw&)8gha(9YEcUcXmez!m=pf`y9bY<~m>1*ZOTLMWc&U;{G!iMy~M!j0vV{d(Ec1~KEcE=n9m2p#y~
zThHg5Jl@M^m&GYL2+6A(lyBazjEbDdizdTclY`9&A@A<0HuXAWb-+>i9{ySa(fynu
zxCJ0Kb%hCZhK7lYAbBb>pT*)>?`O#`$sdQEPv;gS1~^dN*&KY40hj2_kv4VEwaYUG
zngV^XnrOo5)$B}Q+bOMb&EGkgQAH+npucmOx-fkwnt`m3{NWC^UTBtGSd#fFBktX`
zsVgQ+wbZ#`>eY!ABLwR%-_;9
zERr!!DtK}D4I2$ih4c+Nwv2f~rFqx@<(0KTxz-`m@_5&}%#x!jSINA8?+XumvN`Ch
z*OYqBQ#dywtZF*38rxO$hR{}r$HM4%Yu5o=qI5zVzg@~$`Jj~r_;o*_y5p}*fp*cGjEb?#UUUddS54*VI%XZG3Xa8#VepxQL9Yo-
zw-e0r_heBP0kRI@9t6_bI*h=v6ufZhKHbh?VG^;-ejqx0j1c`s@mFkI?+ks
zPs}%qL1zp2-~0PJb)Mj~or!8w508{2UN4GmN;%e-*O0Lx7glS3%~GNZWu@WLIg{2HMi#*7T&Z%~)Gd<83nWmk~DI_)gsz69EYw66G`+
zf~);Idd?Ds^X{LzUzP%YN+4N0vu+Kercw4R6`1r5e4^R&xJ^7L(cVy<-fGh82VO9O#Yqkv{gm?
zC+rHwsmh~At<8xt>gO|~Ob9H!wMi&LA4#`ZD24ErYHOF^U1=vQosu*}>7Sji`B6gF
z%vejsu%jtU|BJ78iqZsFqbxJC(zYvY+qP}nw*Rzk+qP9{+pe^2cHP@+*7WpD&r`g|
zL#&AX?Q?=M@*dDi|B+Jh#S5Ma>YcigTW>6Wy-2uvR=;g?ck8s1SLYMS6is6%+&@qK
z2+aDcQv}s7h50lwx^hg-0SvuZ&g2bKElu;6U;!CgsUi~NozLO)Lc5Zt7YB}r=F;Og
z>L_7_tL`$RLS1iepVsM^t%LK%k99-!R}Wr+5M`;w@CRU;c!ZZgxEWU*)^nNpP_>m!
z$$${%@MWM5f`LJ_ZaAp@ZqjWZMscB^C+dVz-;cT+Dvr_+OMMLyO$DfaZ9IS7yGHxMqY7s>oMthdQa>N*&~48Dpg
z3kyQ)q#Ji^3EOND7LfYqamcnrnTU2XG!#BR2r_$XrV(xf#zj0u6sMTeXuepj-%1lR
zdkgAnLziRaQxRUjOX-f&h436Vtfb!CNe2U87#DC|J*h=KSFAPkZcrt5IH0NCqLzOp
zTjh$+g1FYw77D8D0-eDkgnUafsjry*h+uMaeQAidQpi#Qk#f)N-$9A2TIXl)_J-*!
zgA*6!#=8uZ_WDO5A@y6CBjc<%@lUJvrBhh^-|ze?UXI|}1$PNS@cq=d@2C_kZ4P+W
zdIPi3{SguD1;1)-ktG;TFcx;2?&x#zaUCx1{
zS<8kid=_z}^bw}V%*i@^m(9Ghxnu4!AtWDAmYwZsfe_bCN%)F!STgdJ$@ytoB_Lx#1apM4N-*;n9U!!UGCY&F|B6Cvf
zLY>C}FBsrIi`I5b()ONvraz{u=Vt!`Wx8Cp(J#=+i`U!2bcDX*HP)y+6W@RyQTa~K
zOgF%Emmp4>P#ci=DvoP;huBYU0n|QoT;i{9aTlo
zQ@VKPY$a*;{51lPvL_{y#9h*>+E6bmcD3khHJ>nb{GJZ*%BsIyFw#^2z8p`XeLKsg
zeggK-F~)RXj3QLGp99H;cymA+F%S+!t5rRerEY|D)QR%Gx@wia1hz(X1$NSY4a>Vk
zkH3=8P%A1uq>F>*MoN|9R}@;k`!l#jMeN!jvDesZu^OFF~?PzyI%H55kK|{NnWmD0oxlaCvFADYV3jj?w^{1itotpamJ{
z4!ls^eM7N&ZA#c3HCP!dgsrinK8+xWkyZPTLL;hp3{jVp&M#~JWJ~$lb0W0qQ2^t
z|ArT~G&%kk$p3%&>GWd%7161+2>uU{zfmgyz`@M?zd`>0i0JJJ|5HS74OqIBg|Z+~
z$XGPJ@$%JZ58$QoVSx3P!}D0a~m)BVHzfT({adY|X>JrSK-Ly}tB
z`k19++RxX=D*ew>*JPc3-xk2<>wdATSArAD`R(ps5l(B@u&7>fI(Y%z4qcLZ8vc*Y
z&Bs?>N&DwL;9@OJe?O1u>+PdX|NA2gQLXN$t*vV3TN}zSHB0|zaq1$EPS>r?wCk~5
zSGIF<;>jKbK;JhyDYRSb*0r7f^m66cr?>XqyIUN5VuSlT^qxKJdx#$G=B~n41LNAa
zYu%$RN`6HA+JZ%sKhZvt-{v3;e-M%@A%(2(%VNtm^yksg;Dc878E)1=GOj-g!|rp`
zjj)lziK=Pcc2WAEBQn_an~xTzkYcttlPdmbV!)voK*6=lgG4=-xY2$4*IimK4U-9?
zmsY^K*Qbk0L{)3WHNEd2jG|V=MHp1_lDIrt*%VX}iT!uC
zh`q^xod%Nowp9`615&sqB2YVoted~JoHdT=k@QT!E_HQNN-faN8kdbXgFDG0dUHGv
zn87PVr-EY-H6ruvP*@E;6jPQ&O2~m@&HO~cRdgH#1&*ylGFYNU)
z5!#Ez37zhhB*pB*I-k`0bmL>Np|{X>)39~`QtEorvS^(3#CBsYXikM7)Uj`y9o#JC
zg$aY{njw3St!vLUg)D18>Z_=vVgDp3rj*U+ebjMvq9JZps|pbm8#U7kS@+Ju=)D-k
zLX&BvefY$1VM5|LRFV)Gi7|vitO2$TF3;3RX<84)LmreSP$EmIw6P46d7u_b#-b5`b?n9pZ|7K(LYzV%H#&{I~$(fPoQo^j0buT_Jwnr3UoBEg{i!-_(A(z$<
zx7bf4`)ho^`&+tU{}S2;O2$pmEg;AFK=F{)OLz483;@5nRSPq65zcK{oUgyo>cPVA
zhMUSjrlg`C1tr0~K-7O;K|%x;tydae+e!BwAJ}Xg{_p1DPc$r`Qe524N^}EgCq+;d
z@^D_^y4DytP9mAo;M819V_1_W%UE*Xuj-`vcbva^QO4&f&<`p<8*#b^bvy}jhsTP!
z-be1ocy+tA;*?EgDy;}w+q6l5;Qz`
zb-f{K);ail?PNGVkXSd;-L(Pm0a1`PQ?f~Qx8Yj+(>1ZSVN;CPIng?v6Kq@MM3MT5
z)Ai$O3y8UBZtSotXu^F2eKl)yZ>feL`hm*wG&V(Z?Tr=kmbB
z4t_I4#_3;r>;t=KOR^wFe%SL1QPE&0P`NHP5wDk|iS0qCtmindSdM0M!;Dj(k=?j+
ztlkCELdnHmC>PH>FerMLOldf#3V8M;iGqB^PZ4{uV$UU=mQw)e#bKmqS5f3cbx$Jm
zvLTs0VOA-Z$eLcqW(;Q{R;p_n;~58;7G1^$lv3Sl@pn_t4?mk03-QCou}2k;{ncdN
ze_s`|*>!yvQsv(DLqNPGV&)^VS}a1CyfhL%jwULvtF@~qa{wuwzBa&?!=H#3)sKO*
zF{TxknUq8)R`UUnLTiR$8j6nIL6D)LXL|qiJow|8VKQ7!S0*Ws%6aYFef!wxOb-)!
z5FwWyGxX;qD};;B%P`m>g@}I$q4OnYSskIlrjv@nGLZ(;M5hd>(w_}EC3+J+LgX+c
zNhS7F#xpsQW=~L8|M{yfq1IP$MXV&EzXy4=&Ded7YDNI~ow^XJyL5i6Lw4O!uhess6lx>^xqt!wwwHenGPt>ePsZ6)>5;u8cL7)p$Tlyf&X;
zC9q6}15(TlrdB?pJ1Qh_{C0KQOzLU$x)
zD{LpUpPIb??TMEjS4BzoU@qhIH1gV-H(p!xqBabWhi_)KDRpFacB+YfnoP}G!+7Xd
zLCJtl)8s~}Qk1D>8ZVGQJJFw1HU}MfDooH;&yPbdz6TYAl_m%l|I^fYixL{*t^9Qw
zRO_zll7x=5`u9)m)j$%HAbN_5`waz1e7^gTTdd>_Yw?`sjj&MmNT_>1)&Q)nWYeFWxEb#3SLE8$BB`Xu9sh<*@Qa9f
zC?!Q0X1aleQ0ICss>oCi1>PfTVHF&gn5ZrQLUpWP%`zwFp><6LDn#u$#c!O>iefDl
z18x!9NOA;3+6ie5tH2m4g5BTQb{KY5#ZLKdRp}d0K;pnQ}VLb|9#l!e`tqYGp(xBjtm`%Vn1%>;%#o=x4sWO$T52KHSlL
zfYvubMBiM}%~Qzn+$i5tEw2h7IVVqeQeX>aVh>=MbIqV(KR2RyiUF0**2KvAub~pH
z6Fs)WQ>|NDlX2QDEbAqb{E`oc72R3wfl`4FnH|PeVYjGdGHB^qHorzFRly~ckaUqe
zkeq$dY$v3us@iOD2-9o>32)R#T52!Hp-c#A{*%1^6B_N!S)5QjW&PZz$d0$k3
z)+^KIkwOB#wAl^DV99
zjRTypx@%Y7`YQ7R{_6n1w>8cvcyJ==T*!p(EN$92y67QFP;RTzV5d~e9G0L4^Y5`5
zY}kIGdMeIX)#&gooZK_uo@NxrQbj%=-};AU3oOy54h?bLuF5?KsF^nbxbs{Vrt4|UDwkSf_(q`isn|3Nn
zYiP?Ny=Ix3gNBWq+oa>a6xed_&BSV|4U@WcUibrUVRBj?jggb`Z$M2>&s7}DcxOW}
zs`O0T#cjd9boUh>vYcs0vW7278iwlM+CfvAoRxZ&koW_(a)Mo!ohfF>u8ym!LyYbo
z#R+T3V2c+rC;tNQ*u#blb$0zyDco=ypep|Z;RACYh`J~F9$lr(A-Aw*qqJ+k))06e
zSQ_ccQpX=gw#ew9wBkLnl27e_0n7+2!^Kqwc>^T
z^)ChkU1;J2*dqhQ|B9mhmv>1|2<)A>m{A}f$_&kq9caN6;3>yQhMf#Kb+|-SwN;#U
z>6a^s=37!h(tOl=qzKA#F@E#zkNAv8j90bxg;UX*VyPCt8mHvoovcA|zA-@vV0zP8
z<2-tu?`$*AaATTohzO11FVo)$4PG-W(&0IGY>%e|kTWRl$_b9=SS8P_HwVI}S)FJG`vrvNXv4
z3b3bnwUj~+!JoL_Yj$>0qK|!x)mqq`r~h5|vnO8YXJ20-jt6ev7(hsyGy@jwj-V6h
zj|)!$*b<9*I$L8%2uL2WliFylrV@iha`B<}Hzmfp4LW#(q_>P)w65pklFqNlh7v#Z
zg587u!|q?4J26VEw4p@{$>eNbKv3~Qu}Ydvhe?MP9Ww3k?Ul=m?HdH@sEc70gPGt{
z^%rahFV9K?u{_a%pNUf5KPp31a59oZ4An*e-Q_|l%w5@IAr@>oblG9hU&}O`ukOrr
zW8|Yk&GShYcx5sB8$fgAHK-lvEKQZTmdPdcR#@~@tM_(uvj@4ozM{#2505n(WSa>~g!WI}CMDU~T^1#+nHg+12F>!G5Ud{0S-zq&fzEG+
zUCzbujPp5e17mJ$260RbIVEI4&<&GamFieZok0#(_SLivaCfCw6_Mmg4X+#
zqA%Xg(QWF__8#7u1n!Zs#m>`3Jafv6o4cx1RmUkupMtC>|9jgbq_x36Xu=C0-XW|4
zxFCJyFLa*vKB^{)+z2388JY*?o5COzG|1lDDULk2--4rRgqb%I`~^%fE)WX9;7O>f@524Do?nS|wsQGUS7;L3k9Z
zC?8vj>L2PE2?^nKCz=idqqap$rAhN~96TF}d9h6Cy0GA4XI~&6uV{Q&WN!nsn^$$U
zZB+c5dIKLFIr)dH#B4A2X&Vp#wD?qRIDP^28bOih%R7jDrJPWumis^>#bsDmQtYR^
z$2)N*k1?kRRWq9!c&ICI)JP>*^Aj7XQf$nq+E=LY@_xBl5ic3b)-!4|_oOrPq}v`g
zeVDNSA9q+$EU9OB#`nLqteRq}vhv#s))K&2^DOUlF%Z+)
zpidDdu+0xHSMt)GKulQWV+2M`>c^CN9`9t$@roVI<*b2>QBH%@&*7C1YFMe0B*&-l
zi;9phs3`wc0EE}CbuG4a+}V%l3mTN=$?E`3|GU{MkR($~K9$zN@?noqcHPbofts=%OWZ;>#K!$-w9_5`NkM$M=q15NiQaUfeD$Vb!OG5MXmpF
zzCx3&-7c*{aIh>j(RfDkw>Ge^hG@U_sb+UYj?I$V`=S+OV!2g=swVylA}-2%VVpyA
zFg9}sUV(7vX*I)Oq56PY72Pn&I`XkND)et}UGb?7!2Bpj=P@9=#5Fw1+#7+HZY69)
z;+Us9wspN>q47M^>-!KmBTBN;zKba9ku3k#Ki_9zP}hpX>xrciFyiQA(an_K4bj`S
zVN!eQd#91Tzg2Z9T4j?rIlVltImX%efkp#ZJv4-Np)f=IMyJOr*?{Ms#W_9
z`N62*L^1!6;|3T9izYx~$6=MQO^Rvve@%xHV>m<+mws)svRQtPVc9j@j8EixD<z`qJ`@~R)?)7okp$;~yn1$TOE+TF(BWR;3pBLxK37XttyqH%M6Clk1~o{^tz(
z`xgN23`az#ZgGJAnbC`SK3o(H*fMLqUP6uX#Od&801$&ZV&_CVdf|udqrJLK|K$o0
z{2KpjUeX??LEEfxa`t_EblA&73F7o|YAF=GHQX)ADVx0n-CUWT{iyW&dcxa`xNsRs#@lfaAWgue4`Xfm*;p30GC7
z8cbV@_j4L_Vd%2n>F?KM78fc$%6akfIT#t5FLc=haFEz(h#AA+a#;_IxEr+_Eeiz{
z4@=($YvP?xCp8HZ?r(Q6na_p#olo$eUn8YAOaGRcq_XgKY9`S-rUcxEuiEUuJ*LO?6eRb$#XF&}{NVe!F7+U4y$-hTXvgpTDd_Me&+aGxA?&(7T|GU&w}%h@&-Q<={M&zB`N3VkuJ14YuRFJ{?k|tN
z&)FAyfDzKikI?OZAbLxbTAIOOW98(}_ti%m;HzuWez&jZ>+}06P2M-b3F-L$fxi#1
zxr>hBso4ge+~Lthr>E=pz52Y9_f0f>wEDBT(ff)0lYBPI@B8y?PcMW?ADr9<===N}
zz1ih!E&VzAXqz0(+oi{lYVrY@&Mo4k(Lw}dB1jSY0@^?Ck{MVnnMxoxZQLL?$>c(8
z@1qe{c51CYHYcubUa}^C-a5ZFZ9)I(@U?#4l~>c3D0p@k-*vN_Xg?iohj!||JR4~w
zfb;#bg;M=XuSex?pJ{qLk=Lbj?a!xIQjNzb-`(%|lHJ#eY1FYX#8c+q;^hHLzAAuC
z0A5^mw`9Zz>s`v{iTAn6pQ^co@1^PnLJ^3}!N(%iiZqdMv{7n^;cv67*n1#Yyf&ho
zwKb!RBI8VH>IjvCSXV9!I7c%X0p?`>iO0f%6xVjjr$FC`2_hh%4gr}XMU%>Cofm%YW12cV99>O&$7OB@rg
z6ptPv_dW(kzGGT$pY33(a0~F;PMAAs?lbb3Gk#lR9LgZDkV9Vlg6xKt6k|4q?Lk;i
zm9hy7rNkq7Xyvdc)g(3wS%e%cOOtn8ZWWp%s|~Xe2UoRSV_nM#xI1W|!efK+IGog}
zHDOM_UIMbf@?})d<}XrMDaDoh9J%C0%8c%Mi{*zlku*>9THAL!Rt#Vkdz;7L%QaN~
z)OO`)Mn>hFe$q05rRp{MczJB)HmNOC1LJRcjUu)2rupgxqnTI&B-Nj!?^^=FBoazn
zlC!{d;&s*2lx8aEOs><#tBs+s->uDS7SeUA&=4C85t&aKONX3<&Ry7$Oj_|u9b6E&
zoMvtdoN_B@Y#$&*kZb_8v+A8Y2BJqpk_0!^sCeJl=QG#-6~z;#pxM&(b`VJCj;$KI
z`A}u|bwq<0Afrz7RTuLojs|R7*O7}g{b6J_eknL|X)KveYox*gm)$nM3V(VshxZ$S
z8Z>%rYJS=cZyOg-X-#t4L^dzS&OQlZSdu(oIjmHUHi}(BJ5a!B!mNLOv4O}|CKJ#y_9;p=49f*q>bTpA9ZibO*!iFvB&w2wX
z$6b=qyGlXnX0xAX!0*4s#)!~148{BI2V=!@RB&$br8@^rThisN%YtM(hmI;DH~2j$
zN$h8F&T1aur=tKSONA&s?resk;-Ra^i&bxV~Ce9d2}QAl7V(jHO>
zq%4?|vRc$d*}yGIl&NT_;`i^iF~~TV%qU~}ccq4EQ;d#*IYrg-4as4yCeSiq-?;I5iWEMh@V+OKyqoLvIm>vms3jd{Q0^?)F7P?et
zclAh6QWZc_J13==Y2-u57n4zhzw7~Hp28T{!DlSN(v5*q`WVjegu?J}lOUo)BgbjI
zN{FgKjuOI>g`^z)#g+P4Q$fG%Mg{DgQ}jfV8TAQMLPl;A9`%krT@a0S-Y^cWMwZQ=
zh7HGB4UWV-Jnzm_&>XxMgJtHaPw!~z?MA0)93nu_)2&T#UU^_vetKylLD*kX+-5IY
z8g&9aVYTnIC!!jKNUj9TMWm%dUKgWObx19za0yX2^4f-od@I-xS{9Hv6T>7XeRSMZ
z`A+jQbTW=hbKVR!fvqRByHfg7{igtGJg|Ax{2X{U_7(<1VM`C*EB}^4Gg6{-0)(i#
z(KY}cBm6JA<;-qi9=x^8MWaPaYq5uHm{JACQlAUS!B)s2Cqy5PYmXjybLzSbN|5}N
zOSR(l`i|WBYlEkNj|eg8kK?!GkJgQ$~mH}3ZW`Yg2SwHd3`~9llCEjHhLL{-xghlJUn@U
z6ZG%%uFzCn{!2zbuUCg(oTn|PM?D!qxxQ;&$i;Ooony`X{7%axb+;iZ6Qx^7HK7Dp
zH$%31@4(=cA)?43Q1vzwkS*}Gf$6P+i03D=ODh38WUdn$S+Yr4g4ms(gL`i&=9SCb7JEx)O7yv|{>
zj}aJw(oA+`NtsQOw}j)lwTq44It5~FFE(vz2(f-UhmRspXa$FDsGzy{k7ksEm6us{
zq}fp@bfS-^yy6}k^I}mqj?j%bH)3?9hRqeDyRkc8RoWU1rLqw|IH4Kd5QqaxN|5!y
zi>)*gS8R%9bLujWOjls^@6sE1bH(HrMWfu4{Y(#=IZ?+aToR3*HuDgsT~cxfFL8;b
zFhk^LFb!rk!{b%G7~R*LEpBA0_$9o>t4JM&j$|?m`x@oSIdbze^@Zz0B
z0QHtd$~U)ER5;QbYGftkdjSMDH&($BW?&tX~u<yOPRMwdyAh0p;E!yhPkm9rZMsu0E_3?%?(kI`$c~xMM@+3k-~(jPQDSme%rXE5!qnbR(Ldh#$;dPyY*UOl8Vim+I8^?52xD#7k#=gba?}CVmx>t-T)1xn_YKp
zM6>DE1iiTG7(kf!?GKSbk}J3Rer;e+tYZmIGTwob7A!!uVt}DnqkZi6ch*M%s{nV633-^G0$WW%BqiqG>-!kmfQtoNS
z_|YKihvWb;S9$r5X~L2GRf+{&6zE;#ted3}-D1yUC1v4@tTtvp8
z;A(t9#^5W1NUZ>^{q*yRW6{ort_(Qw5`b`ZW$P|V>FJvE+7qs9b16ZQs_9auw
zi>%MyhklhhgUwcXt;+M{PW(XGlJr`Xvs48Gb?O<2SC?39EiGMI5p5fIvf|>wuXR$iy|?WrVaxB(&r}@NxrLD3~WFGs8~yJ3h5XM
zEF}t2#haEWvFy0b1GWF6uj4$$
zXRu9Zcz^*d4NQej?or_LN~C)b
zU`%Mty^^YqtsV^ka8x5>G(=JwQGoE?x1pcg-BPh4gc>Q6JailXQ!tk@6YGIcXG>Kr^(f
z*LWkv!lZUI4@i|_a{T1O`6)dih~SF9o_+lFVmd_Ee|+O?Kv#rScvAB($ios-7Jrjq
zk^Ax&mqOgIgx{Q})hz?whU>a!2rUBGW_Qtex~i-yKdstN0{FLyvIN|t=-=B&8Qe^N
z!*B83Bui=00HxE0Qn4|Sng%4|Z)oElKl<@Ca^;SkkPEX+M2a>c^+CJea(H|v!{#HC
z86un>Hg!}PLGLpA^w^$ZaWNJ^7iWk1W^4qmxtskPDqGmy%((+f2q@>UA_iF?4o`%r
z9;cxv=1;nbUkCq17V1<5U>s%|n*=baAN`i)(oCsq5!VKJ%Dfs!Ynt_OaZ29aTObkE
z51XunO>d*(bMD|YlNPOnpN!hXyB6pC-O?^rI=9i@0?sa6r^pZHw~HTNzHOtAQ#c9vs|edctQ!?j9~>w6
zB53(oiY&mDdTB?#Mj(*97kO$#1kk;%q1`hh+{j6O(R@E6I7h%#Mf5z0U5&E>ML2fz}JteF^Y)9O~DTpp+&0y#beH=vivu$ONZW
z{hnjzc@xJ$TsxQH$})ErdqW=b)csU^%r`9l!w#6)!gUz9bALxT^SObT^&!zy-a>Sd2(f}IR2
z?*vF_H{)lddxDETDHGvqT4itlNzH0)-2$Kv1A~9z^J`eEkGK4^)IMFh-Wc`ON}wP{
z3nVwev{y45^~}L$38aCM7U9yexl8!V0+}WD>`GSXmyFY`FU~BcpO2GcME8kaH%x
ze&S`4QQgn8Ogism9W7$lVBo)Zi#JpZL13E&mM*P0o_&_tX5+XS;;lzN&~e3NDZYOB
zUofW#6AlzIlA06EO_{08MOK$yX#+?Z!jwfge=#muR0M0w_?j4}p?T@*^~O=}N5Owi
z=MzS@wc5F(?h9=TGf^o?MoQr5C{j4ixcm6LT$3Y4ry!y7Pqb4sz43n42l`J6{qjyD
z{F|NH^+G|Ut@%e3|KRn4i`JRnE_fMNPM)8!ZU!=>x#oaK@hna_&6u)@UjqQ{?AH6q
z+cy&&5PPz=>wyL~Ty6KuBrabhraj;-+by_33xoXQfz#>rfs0yO!`4dRf;;L9i8sAj
zOR151kv-Bj=^waQcvEeu-`(w4T$Qb0SE|twIRRHdvW$@V>$|3=p@|J4^u_L~P&`r4
z`isgvPRx4$s!PJ_Bwf|^kr#khsaa;KEv|^Pr0C7>097zHnMCUbHL^v%J(yxK$_hNd
zXgiq#1J3m3)ecGfrR5(~bQIGdP0+4xL%yms_f*eMPq6O1CuYxBHK%W%8r$|YOnrS}
z^`LNp3?Il=424h_#RjP}p)V@5GsaDP9Z@pf%9Y6^<;q8-S&okF?TiYy8hYBN@?vOO
z_AHlv{sRnzyj%8Prp_M50snv3&-}+sPueBLNJ1m~|NfbE<6kj4qzHmzmMS-f2
z@;`-i4}V@v@BgQe9w->Go`h{Mw=ER`o%qMY=WgyQjQ{7Nu5U|E|DSI8wd>bif&YC_
z*Z1l3F}(}$eETP)e>}T=yx#eJ*N
z#fu%g)zrswfOo@39$n1owLM`h>d*Pyo?Qfe`bz-co%B7*yX=Kb?uU=}U7cq?r+%L~
zw!7EP;)B-TJAP=zl(`ZaD}ZlzZ`~h0KpUAB^lwMq(_))$)Ln$t{md!*Tm-DTva{iF
zde88VYKSQ|1P(<(jkOueKPpdPa>$6D(=3ax#RupnQIG;);7
z8;2XfuHXAhoqn%v^n2bvMZfp!%&%)6C7+%T*e=(F2PokRrYS9FgS=m_rdxY~PQ3N$9^mh{8z|Co?bxS8
zR@~I)oH&t{ohN~lF}4Bz4%7hloP&*_gm-Pq@2)~3DuStG_gn2+7IN!ktJl&%ZVsx8ogUDN#H7UFYey2`}^
z+>?C1ed?(;S(Vpg41h+bUBl@KedfKbkSgiWtDw-D+mTMk4cE{T<1;up_
zL$zXcP8;xb9d8U!u&0upN@zThV5+(fdT(xuFbk
zr5?v)V1!-Yp?A`@Kf`2zf7m0yN_(ViUV^Xs~V>l$SXL
ztwNhlhOSPR`A@EXE?N655$8MFgtkdVeJgdAVUA0`dS!TJ|1T_6&~Hw1{y|{A{X